Substance-attributable morbidity and mortality changes to Canada's epidemiological profile: Measurable differences over a ten-year period

Canadian Journal of Public Health

Volumn 98, Issue 3, 2007, Pages 228-234

  Patra, Jayadeep ^a,b   Taylor, Benjamin ^a,b   Rehm, Jürgen T ^a,b,c   Baliunas, Dolly ^b   Popova, Svetlana ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Institut fur Sucht und Gesundheitsforschung Zurich   (Switzerland)

Author keywords

Canada; Epidemiology; Morbidity; Mortality; Substance related disorders

Indexed keywords

EID: 34447256577     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03403718     Document Type: Article

References (51)

1. World Health Organization. The World Health Report 2002 - Reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization, 2002.
2. Ezzati M, Lopez AD, Rodgers A, Vander Horn S, Murray CJL, and the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347-60.
3. Single E, Robson L, Xie X, Rehm J. The costs of substance abuse in Canada. Ottawa, ON: Canadian Centre on Substance Abuse, 1996.
4. Rehm J, Baliunas D, Brochu S, Fischer B, Gnam W, Patra J, et al. The social costs of substance abuse in Canada 2002. Ottawa: Canadian Centre on Substance Abuse, 2006.
5. Hill AB. The environment and disease: Association or causation? Proc Royal Soc Med 1965;58:295-300.
6. English DR, Holman CDJ, Milne E, Winter MJ, Hulse GK, Codde G, et al. The quantification of drug caused morbidity and mortality in Australia 1995. Canberra, Australia: Commonwealth Department of Human Services and Health, 1995.
7. Rothman KJ, Greenland S. Causation and causal inference. In: Rothman KJ, Greenland S (Eds.), Modern Epidemiology 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers, 1998;7-28.
8. Gutjahr E, Gmel G, Rehm J. Relation between average alcohol consumption and disease: An overview. Eur Addict Res 2001;7(3):117-27.
9. Ridolfo B, Stevenson C. The quantification of drug-caused mortality and morbidity in Australia 1998. Canberra: Australian Institute of Health and Welfare, 2001.
10. Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N, et al. Alcohol use. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL (Eds.), Comparative Quantification of Health Risks. Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva: World Health Organization, 2004;959-1109.
11. Corrao G, Bagnardi V, Zambon A, Arico S. Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: A meta-analysis. Addiction 1999;94:1551-73.
12. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: A meta-analysis. Addiction 2000; 95(10):1505-23.
13. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: A meta-analysis. JAMA 2003;289(5):579-88.
14. Traffic Injury Research Foundation of Canada. Alcohol-crash problem in Canada: 2002. Canadian Council for Motor Transport Administrators Standing Committee on Road Safety Research and Policies and Transport Canada. Ottawa, Canada, 2004.
15. Transport Canada. Road Safety in Canada - 2001. 2004. Available online at: http://www.tc.gc.ca/roadsafety/tp/tp13951/2001/menu.htm (Accessed September 15, 2004).
16. Council of Canadian Fire Marshals and Fire Commissioners. Fire losses in Canada. Annual report 2000. Ottawa: Council of Canadian Fire Marshals and Fire Commissioners, 2003.
17. Geduld J, Gatali M, Remis RS, Archibald CP. Estimates of HIV prevalence and incidence in Canada, 2002. Canada Communicable Disease Report 2003;29:197-208.
18. Remis RS. Estimating the Incidence and Prevalence of Hepatitis C Infection in Canada, 2002. 2nd Canadian Conference on Hepatitis C. Vancouver, BC, March 27-31, 2004. Available online at: http://www.phs.utoronto.ca/ohemu/Presentations.html (Accessed February 21, 2005).
19. MacDonald S, Anglin-Bodrug K, Mann R, Erickson P, Hathaway A, Chipman M, et al. Review: Injury risk associated with cannabis and cocaine use. Drug and Alcohol Dependence 2003;72:99-115.
20. Popova S, Rehm J, Patra J. Illegal drug-attributable mortality and potential years of life lost in Canada 2002: Conclusions for prevention and policy. Cont Drug Problems 2006;33(3):343-66.
21. Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: Review and meta-analysis. Int J Cancer 1997;72(565):573.
22. Simonato L, Agudo A, Ahrens W, Benhamou E, Benhamou S, Boffetta P, et al. Lung cancer and cigarette smoking in Europe: An update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer 2001;91:876-87.
23. Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, et al. Smoking and cervical cancer: Pooled analysis of the IARC multi-centric case-control study. Cancer Causes & Control 2003;14:805-14.
24. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: A meta-analysis of epidemiologic studies. Rev Cancer 2000;89(3):630-39.
25. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies. Int J Cancer 2005;114:101-8.
26. Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, et al. Cigarette smoking and bladder cancer in men: A pooled analysis of 11 case-control studies. Int J Cancer 2000;86:289-94.
27. Brennan P, Bogillot O, Greiser E, Chang-Claude J, Wahrendorf J, Cordier S, et al. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes & Control 2001;12:411-17.
28. Brownson RC, Novotny TE, Perry MC. Cigarette smoking and adult leukemia: A meta-analysis. Arch Intern Med 1993;153:469-75.
29. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: An evaluation of the evidence. BMJ 1997;315(7114):973-80.
30. Law MR, Wald NJ. Environmental tobacco smoke and ischemic heart disease. Prog Cardiovasc Dis 2003;46:31-38.
31. U.S. Department of Health and Human Services. The health consequences of smoking: A report of the Surgeon General. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health, 2004.
32. Health Promotion Survey. [Catalogue 82M0007GPE]. Ottawa: Statistics Canada, 1990.
33. Alcohol and Other Drugs Survey. Canada's Alcohol and Other Drugs Survey 1994: A Discussion of the Findings. Catalogue No. H39-338/1-1994E, 1994.
34. Canadian Centre on Substance Abuse. Canadian Addiction Survey 2004: Microdata eGuide. Ottawa: Canadian Centre on Substance Abuse, 2004.
35. General Social Survey, cycle 6. Statistics Canada. Housing, Family and Social Statistics Division, 1991.
36. Canadian Community Health Survey (CCHS), cycle 2.1. [Catalogue No. 82M0013XCB]. Ottawa: Statistics Canada, 2003.
37. Popova S, Rehm J, Fischer B. An overview of illegal opioid use and health services utilization in Canada. Public Health 2006;120(4):320-28.
38. Rehm J, Patra J, Popova S. Alcohol-attributable mortality and potential years of life lost in Canada 2001: Implications for prevention and policy. Addiction 2006;101:373-84.
39. Baliunas D, Patra J, Rehm J, Popova S, Kaiserman M, Taylor B. Smoking-attributable mortality in Canada 2002: Conclusions for prevention and policy. Chron Dis Can (in press).
40. Fischer B, Medved W, Gliksman L, Rehm J. Illicit opiates in Toronto: A profile of current users. Addict Res 1999;7(5):377-415.
41. Moses S, Mestery K, Kaita KD, Minuk GY. Vital hepatitis in a Canadian street-involved population. Can J Public Health 2002;93(2):123-28.
42. Roy E, Haley N, Lemire N, Boivin J, Leclerc P, Vincelette J. Hepatitis B virus infection among street youths in Montreal. CMAJ 1999;161:689-93.
43. Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics 1976;32:829-49.
44. Walter SD. Prevention of multifactorial disease. Am J Epidemiol 1980;112:409-16.
45. Taylor B, Rehm J. When risk factors combine: The interaction between alcohol and smoking for aerodigestive cancer, coronary heart disease, and traffic and fire injury. Addict Behav 2006;31(9):1522-35.
46. Collins DJ, Lapsley HM. Counting the cost: Estimates of the social costs of drug abuse in Australia 1998-99. National Drug Strategy Monograph Series, no. 49. ISBN 0 642 82181 X. Canberra: Commonwealth Department of Health and Ageing, 2002.
47. Statistics Canada, CANSIM, Table 051-0001. Accessed December 16, 2005.
48. Public Health Agency of Canada. Cardiovascular disease surveillance on-line. 2002. Available online at: http://dsol-smed.phac-aspc.gc.ca/ dsol-smed/cvd/c_time_e.html (Accessed September 16, 2004).
49. Taylor B, Rehm J, Patra J, Popova S, Baliunas D. Alcohol-attributable morbidity and resulting health care costs in Canada in 2002: Recommendations for policy and prevention. J Stud Alcohol Drugs 2007;68:36-47.
50. Rehm J, Patra J, Popova S. Alcohol-attributable mortality and potential years of life lost in Canada 2001: Implications for prevention and policy. Addiction 2006;101(3):373-84.
51. Rehm J, Monteiro M, Room R, Gmel G, Jernigan D, Frick U, et al. Steps towards constructing a global comparative risk analysis for alcohol consumption: Determining indicators and empirical weights for patterns of drinking, deciding about theoretical minimum, and dealing with different consequences. Eur Addict Res 2001;7(3):138-47.